BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37178269)

  • 1. Early (Days 1-4) post-treatment serum hCG level changes predict single-dose methotrexate treatment success in tubal ectopic pregnancy.
    Mackenzie SC; Moakes CA; Doust AM; Mol BW; Duncan WC; Tong S; Horne AW; Whitaker LHR
    Hum Reprod; 2023 Jul; 38(7):1261-1267. PubMed ID: 37178269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose systemic methotrexate vs expectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trial.
    Jurkovic D; Memtsa M; Sawyer E; Donaldson AN; Jamil A; Schramm K; Sana Y; Otify M; Farahani L; Nunes N; Ambler G; Ross JA
    Ultrasound Obstet Gynecol; 2017 Feb; 49(2):171-176. PubMed ID: 27731538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hysterosalpingo-foam sonography versus hysterosalpingography during fertility work-up: an economic evaluation alongside a randomized controlled trial.
    Kamphuis D; van Eekelen R; van Welie N; Dreyer K; van Rijswijk J; van Hooff MHA; de Bruin JP; Verhoeve HR; Mol F; van Baal WM; Traas MAF; van Peperstraten AM; Manger AP; Gianotten J; de Koning CH; Koning AMH; Bayram N; van der Ham DP; Vrouenraets FPJM; Kalafusova M; van de Laar BIG; Kaijser J; Lambeek AF; Meijer WJ; Broekmans FJM; Valkenburg O; van der Voet LF; van Disseldorp J; Lambers MJ; Tros R; Lambalk CB; Stoker J; van Wely M; Bossuyt PMM; Mol BWJ; Mijatovic V
    Hum Reprod; 2024 Jun; 39(6):1222-1230. PubMed ID: 38600625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study.
    Koedooder R; Singer M; Schoenmakers S; Savelkoul PHM; Morré SA; de Jonge JD; Poort L; Cuypers WJSS; Beckers NGM; Broekmans FJM; Cohlen BJ; den Hartog JE; Fleischer K; Lambalk CB; Smeenk JMJS; Budding AE; Laven JSE
    Hum Reprod; 2019 Jun; 34(6):1042-1054. PubMed ID: 31119299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies.
    Goh A; Karine P; Kirby A; Williams C; Kapurubandara S
    Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():105-110. PubMed ID: 33113399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol.
    May J; Duncan C; Mol B; Bhattacharya S; Daniels J; Middleton L; Hewitt C; Coomarasamy A; Jurkovic D; Bourne T; Bottomley C; Peace-Gadsby A; Doust A; Tong S; Horne AW
    Trials; 2018 Nov; 19(1):643. PubMed ID: 30458863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can hysterosalpingo-foam sonography replace hysterosalpingography as first-choice tubal patency test? A randomized non-inferiority trial.
    van Welie N; van Rijswijk J; Dreyer K; van Hooff MHA; de Bruin JP; Verhoeve HR; Mol F; van Baal WM; Traas MAF; van Peperstraten AM; Manger AP; Gianotten J; de Koning CH; Koning AMH; Bayram N; van der Ham DP; Vrouenraets FPJM; Kalafusova M; van de Laar BIG; Kaijser J; Lambeek AF; Meijer WJ; Broekmans FJM; Valkenburg O; van der Voet LF; van Disseldorp J; Lambers MJ; Tros R; Lambalk CB; Stoker J; van Wely M; Bossuyt PMM; Mol BWJ; Mijatovic V
    Hum Reprod; 2022 May; 37(5):969-979. PubMed ID: 35220432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Top 10 priorities for future infertility research: an international consensus development study†  ‡.
    Duffy JMN; Adamson GD; Benson E; Bhattacharya S; Bhattacharya S; Bofill M; Brian K; Collura B; Curtis C; Evers JLH; Farquharson RG; Fincham A; Franik S; Giudice LC; Glanville E; Hickey M; Horne AW; Hull ML; Johnson NP; Jordan V; Khalaf Y; Knijnenburg JML; Legro RS; Lensen S; MacKenzie J; Mavrelos D; Mol BW; Morbeck DE; Nagels H; Ng EHY; Niederberger C; Otter AS; Puscasiu L; Rautakallio-Hokkanen S; Sadler L; Sarris I; Showell M; Stewart J; Strandell A; Strawbridge C; Vail A; van Wely M; Vercoe M; Vuong NL; Wang AY; Wang R; Wilkinson J; Wong K; Wong TY; Farquhar CM; ; AlAhwany H; Balaban O; Barton F; Beebeejaun Y; Boivin J; Bosteels JJA; Calhaz-Jorge C; D’Angelo A; F. Dann L; J. De Jonge C; du Mez E; A. Ferriani R; Gerval MO; J. Gingel L; Greenblatt EM; Hartshorne G; Helliwell C; Hughes LJ; Jo J; Jovanović J; Kiesel L; Kietpeerakool C; Kostova E; Kucuk T; Kumar R; Lawrence RL; Lee N; Lindemann KE; Loto OM; Lutjen PJ; MacKinven M; Mascarenhas M; McLaughlin H; Mourad SM; Nguyen LK; Norman RJ; Olic M; Overfield KL; Parker-Harris M; Repping S; Rizzo R; Salacone P; Saunders CH; Sengupta R; Sfontouris IA; Silverman NR; Torrance HL; Uphoff EP; Wakeman SA; Wischmann T; Woodward BJ; Youssef MA
    Hum Reprod; 2020 Dec; 35(12):2715-2724. PubMed ID: 33252677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in serum human chorionic gonadotropin levels 0-4 days after methotrexate administration for predicting tubal ectopic pregnancy treatment success.
    Wong L; Fung LWY; Cheung CW; Lao TT
    Int J Gynaecol Obstet; 2018 May; 141(2):245-249. PubMed ID: 29214643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a decline in serum hCG between days 0-4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study.
    Skubisz M; Dutton P; Duncan WC; Horne AW; Tong S
    BMC Pregnancy Childbirth; 2013 Feb; 13():30. PubMed ID: 23369098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose versus two-dose administration of methotrexate for the treatment of ectopic pregnancy: a randomized controlled trial.
    Song T; Kim MK; Kim ML; Jung YW; Yun BS; Seong SJ
    Hum Reprod; 2016 Feb; 31(2):332-8. PubMed ID: 26701971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative live birth rates in low-prognosis women.
    Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; van Golde RJT; Hoek A; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Torrance HL; Broekmans FJM;
    Hum Reprod; 2019 Jun; 34(6):1030-1041. PubMed ID: 31125412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.
    van Mello NM; Mol F; Verhoeve HR; van Wely M; Adriaanse AH; Boss EA; Dijkman AB; Bayram N; Emanuel MH; Friederich J; van der Leeuw-Harmsen L; Lips JP; Van Kessel MA; Ankum WM; van der Veen F; Mol BW; Hajenius PJ
    Hum Reprod; 2013 Jan; 28(1):60-7. PubMed ID: 23081873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the Additional Dose Requirement be Determined before the Seventh Day to Successfully Treat Tubal Ectopic Pregnancy with a Single-dose Methotrexate Protocol?
    Akselim B; Karaşin SS; Sabır YA
    J Coll Physicians Surg Pak; 2021 Sep; 31(9):1046-1050. PubMed ID: 34500519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.
    van Tilborg TC; Torrance HL; Oudshoorn SC; Eijkemans MJC; Koks CAM; Verhoeve HR; Nap AW; Scheffer GJ; Manger AP; Schoot BC; Sluijmer AV; Verhoeff A; Groen H; Laven JSE; Mol BWJ; Broekmans FJM;
    Hum Reprod; 2017 Dec; 32(12):2496-2505. PubMed ID: 29121326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder.
    Oudshoorn SC; van Tilborg TC; Eijkemans MJC; Oosterhuis GJE; Friederich J; van Hooff MHA; van Santbrink EJP; Brinkhuis EA; Smeenk JMJ; Kwee J; de Koning CH; Groen H; Lambalk CB; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2017 Dec; 32(12):2506-2514. PubMed ID: 29121269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to resolution of tubal ectopic pregnancy following methotrexate treatment: A retrospective cohort study.
    Davenport MJ; Lindquist A; Brownfoot F; Pritchard N; Tong S; Hastie R
    PLoS One; 2022; 17(5):e0268741. PubMed ID: 35609041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.
    Fernández Sánchez M; Višnová H; Larsson P; Yding Andersen C; Filicori M; Blockeel C; Pinborg A; Khalaf Y; Mannaerts B;
    Hum Reprod; 2022 May; 37(6):1161-1174. PubMed ID: 35451013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Top 10 priorities for future infertility research: an international consensus development study.
    Duffy JMN; Adamson GD; Benson E; Bhattacharya S; Bhattacharya S; Bofill M; Brian K; Collura B; Curtis C; Evers JLH; Farquharson RG; Fincham A; Franik S; Giudice LC; Glanville E; Hickey M; Horne AW; Hull ML; Johnson NP; Jordan V; Khalaf Y; Knijnenburg JML; Legro RS; Lensen S; MacKenzie J; Mavrelos D; Mol BW; Morbeck DE; Nagels H; Ng EHY; Niederberger C; Otter AS; Puscasiu L; Rautakallio-Hokkanen S; Sadler L; Sarris I; Showell M; Stewart J; Strandell A; Strawbridge C; Vail A; van Wely M; Vercoe M; Vuong NL; Wang AY; Wang R; Wilkinson J; Wong K; Wong TY; Farquhar CM;
    Fertil Steril; 2021 Jan; 115(1):180-190. PubMed ID: 33272617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis.
    Colombo GE; Leonardi M; Armour M; Di Somma H; Dinh T; da Silva Costa F; Wong L; Armour S; Condous G
    Hum Reprod Open; 2020; 2020(4):hoaa044. PubMed ID: 33134560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.